Related Experiment Video

Updated: Sep 30, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Neonatal glucose metabolism: differential diagnoses, evaluation, and treatment of hypoglycemia

Richard M Cowett1, Jeffrey L Loughead

  • 1Neonatal Intensive Care Unit, Central DuPage Hospital, Chicago, USA. rmcowettmd@att.net

Neonatal Network : NN
|June 25, 2002
PubMed

Insights

Neonatal hypoglycemia, or low blood sugar in newborns, poses significant risks for long-term neurologic issues. Management is complex due to undefined glucose thresholds and variable infant symptoms.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Neuroscience

Background:

  • Neonatal hypoglycemia is a common clinical challenge.
  • Emerging evidence links it to potential long-term neurologic deficits.
  • Management is complicated by undefined glucose thresholds and variable infant presentation.

Purpose of the Study:

  • To define the range of euglycemia in neonates.
  • To review the differential diagnoses and causes of neonatal hypoglycemia.
  • To outline the principles for managing neonatal hypoglycemia.

Main Methods:

  • Literature review on neonatal glucose metabolism.
  • Analysis of clinical care issues in neonatal hypoglycemia.
  • Synthesis of diagnostic and management strategies.

Main Results:

  • Neonatal hypoglycemia presents with variable signs and symptoms.
  • Many affected infants may not show obvious impairment.
  • Neonatal glucose metabolism is complex, with various conditions causing hypo- or hyperglycemia.

Conclusions:

  • Establishing and maintaining euglycemia is critical, especially in vulnerable neonates.
  • A clear understanding of hypoglycemia's etiology and management is essential for neonatal practitioners.
  • Further research may clarify optimal glucose thresholds and diagnostic criteria.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...